BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 10202280)

  • 21. Tumor mapping of regional immunostaining for p21, p53, and mdm2 in locally advanced bladder carcinoma.
    Jahnson S; Karlsson MG
    Cancer; 2000 Aug; 89(3):619-29. PubMed ID: 10931462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscle invasive schistosomal squamous cell carcinoma of the urinary bladder: frequency and prognostic significance of p53, BCL-2, HER2/neu, and proliferation (MIB-1).
    Badr KM; Nolen JD; Derose PB; Cohen C
    Hum Pathol; 2004 Feb; 35(2):184-9. PubMed ID: 14991535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical expression of retinoblastoma gene product (Rb), p53 protein, MDM2, c-erbB-2, HLA-DR and proliferation indices in human urinary bladder carcinoma.
    Ioachim E; Charchanti A; Stavropoulos NE; Skopelitou A; Athanassiou ED; Agnantis NJ
    Histol Histopathol; 2000 Jul; 15(3):721-7. PubMed ID: 10963116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue.
    Stefanaki K; Tzardi M; Kouvidou C; Chaniotis V; Bolioti M; Vlychou M; Zois M; Kakolyris S; Delides G; Rontogianni D; Georgoulias V; Kanavaros P
    Anticancer Res; 1998; 18(4A):2403-8. PubMed ID: 9703886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of the apoptotic index analysed jointly with selected cell cycle regulators and proliferation markers in non-small cell lung cancer.
    Dworakowska D; Jassem E; Jassem J; Karmoliński A; Lapiński M; Tomaszewski D; Rzyman W; Jaśkiewicz K; Sworczak K; Grossman AB
    Lung Cancer; 2009 Oct; 66(1):127-33. PubMed ID: 19200616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel p53/p130 axis in bladder tumors.
    Mudryj M; Reay E; Beckett L; Dandekar S; deVere White R; Gandour-Edwards R
    Urology; 2007 Sep; 70(3):608-12. PubMed ID: 17905135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
    Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
    Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of MCM2 immunoreactivity in stage T1 transitional cell carcinoma of the bladder.
    Krüger S; Thorns C; Stöcker W; Müller-Kunert E; Böhle A; Feller AC
    Eur Urol; 2003 Feb; 43(2):138-45. PubMed ID: 12565771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
    King ED; Matteson J; Jacobs SC; Kyprianou N
    J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of apoptosis and apoptosis-associated proteins in salivary gland adenoid cystic carcinoma.
    Jia L; Esguerra RL; Tang X; Yin H; Sakamoto K; Okada N; Takagi M
    Pathol Int; 2004 Apr; 54(4):217-23. PubMed ID: 15028021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
    Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
    Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma.
    Uchida T; Gao JP; Wang C; Jiang SX; Muramoto M; Satoh T; Minei S; Shimura S; Irie A; Kameya T; Baba S
    Urology; 2002 Apr; 59(4):615-20. PubMed ID: 11927338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer.
    Stein JP; Ginsberg DA; Grossfeld GD; Chatterjee SJ; Esrig D; Dickinson MG; Groshen S; Taylor CR; Jones PA; Skinner DG; Cote RJ
    J Natl Cancer Inst; 1998 Jul; 90(14):1072-9. PubMed ID: 9672255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-expression of p53 and MDM2 in human atherosclerosis: implications for the regulation of cellularity of atherosclerotic lesions.
    Ihling C; Haendeler J; Menzel G; Hess RD; Fraedrich G; Schaefer HE; Zeiher AM
    J Pathol; 1998 Jul; 185(3):303-12. PubMed ID: 9771485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of Ki67, TP53, MDM-2 and BCL-2 expressions with WHO 1973 and WHO/ISUP grades, tumor category and overall patient survival in urothelial tumors of the bladder.
    Gönül II; Akyürek N; Dursun A; Küpeli B
    Pathol Res Pract; 2008; 204(10):707-17. PubMed ID: 18572327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 and related proteins in epithelial ovarian cancer.
    Sengupta PS; McGown AT; Bajaj V; Blackhall F; Swindell R; Bromley M; Shanks JH; Ward T; Buckley CH; Reynolds K; Slade RJ; Jayson GC
    Eur J Cancer; 2000 Dec; 36(18):2317-28. PubMed ID: 11094305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).
    Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Carrasco JC; Requena MJ; Montironi R
    Eur Urol; 2004 May; 45(5):606-12. PubMed ID: 15082203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant peripheral nerve sheath tumours: high Ki67 labelling index is the significant prognostic indicator.
    Watanabe T; Oda Y; Tamiya S; Kinukawa N; Masuda K; Tsuneyoshi M
    Histopathology; 2001 Aug; 39(2):187-97. PubMed ID: 11493336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder.
    Yurakh AO; Ramos D; Calabuig-Fariñas S; López-Guerrero JA; Rubio J; Solsona E; Romanenko AM; Vozianov AF; Pellin A; Llombart-Bosch A
    Eur Urol; 2006 Sep; 50(3):506-15; discussion 515. PubMed ID: 16624482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue.
    Xie X; Clausen OP; De Angelis P; Boysen M
    Cancer; 1999 Sep; 86(6):913-20. PubMed ID: 10491515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.